DarioHealth Corp (Warrants) fka DRIOW

[pointofend]

The parity ratio should be closer to 1.2 but I am happy with the $1.3 it is currently and I think it will fly with any news.

There are a number of things that the company needs to update us on to achieve a share price of $20. Some of them I can think of are:
1. Insurance reimbursement.
2. Android app approval in US.
3. Better payment setup and availability on Amazon store.
4. Rollout in the countries mentioned for 2016.
5. Start development of other or new products.
6. Better marketing strategy.(They are not good at social media marketing).

I feel that the company is slow in execution and this is the biggest risk on this ticker as time may run out for them.
Since the US rollout was almost at the end of the quarter I am not looking for astonishing numbers. Their subscription model is what will kick up the sales figure up a few notches but beyond the next quarter (Q2) it will depend on the above factors and the execution speed.

I am generally on top of things on this but if you have any information of labstyle's progress feel free to update on this board.

Its good to have a meaningful conversation rather than deal with a joker like Nirk. He is sometimes entertaining though.